In conjunction with our previous insight (see the January 24, 2012 analyst insight), another company focused on sublingual drug delivery also made recent headlines. Kedem Pharmaceuticals announced a collaboration with Novartis on the...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)